Bills: HF2354, HF1672, HF2389, HF2870, HF2743, HF1918, HF2551, HF1671

Keywords: medical assistance, fraud prevention, subpoena authority, criminal penalties, consumer protection, medical cannabis, medical marijuana, cannabis, cannabinoids, hemp, marijuana registry, patient registry, visiting patient, Tribal cannabis, Tribal medical cannabis program, Tribal sovereignty, Office of Cannabis Management, designated caregiver, home cultivation, adult-use cannabis

Bills: HF2354, HF1672, HF2389, HF2870, HF2743, HF1918, HF2551, HF1671

Keywords: medical assistance, fraud prevention, subpoena authority, criminal penalties, consumer protection, medical cannabis, medical marijuana, cannabis, cannabinoids, hemp, marijuana registry, patient registry, visiting patient, Tribal cannabis, Tribal medical cannabis program, Tribal sovereignty, Office of Cannabis Management, designated caregiver, home cultivation, adult-use cannabis

Transcript Highlights:

• Retailers are currently using hemp-derived or synthetically altered cannabinoids like Delta 8 to sell
• The legislation bans synthetic or artificially manufactured cannabinoids made outside the physical plant

Bills: HB305, HB395, HB341

Keywords: hemp, marijuana, THC regulations, cannabis products, adult-use industry, public health, youth protection, child support, reunification, Department of Services for Children, family court, liability

Summary: The committee met in late June with Senators Hansen, Buckson, Siegfried, Townsend, and Huxable present, and first approved the meeting minutes by voice vote. The opening bill, HB 341, would limit DFS from filing child support in foster care cases unless doing so would not hinder reunification; Children’s Department staff said the department has already decided to stop filing in all such cases, with an estimated fiscal impact of about $140,000 annually. Public testimony from the League of Women Voters supported the bill as a compassionate measure to help families reunite. The committee then heard HB 446/related anaphylaxis legislation for colleges and universities, which would allow institutions to stock and use intranasal epinephrine alongside auto-injectors and update training and reporting requirements. The Asthma and Allergy Foundation of America supported the measure, emphasizing the need for needle-free options and faster treatment of anaphylaxis. The committee also took up HS1 for HB 356 on PFAS, which would ban firefighting foam containing PFAS beginning in 2028, require disclosure if PPE contains PFAS, and address recalls; DNREC and the fire service supported it, saying most departments have already transitioned away from PFAS foam. A major portion of the meeting focused on HB 305, a diabetes wellness pilot program that would use continuous glucose monitoring, app-based care coordination, lab testing, and DHIN data analysis to shift care toward prevention and remission. Sponsor Senator Siegfried described the bill as a response to Delaware’s high diabetes costs and prevalence, and the Medical Society of Delaware supported it as a proactive model. The committee also discussed HB 395, which would regulate intoxicating hemp-derived products and synthetic cannabinoids by classifying products over a THC threshold as marijuana and creating penalties for unlicensed sales; the Office of the Marijuana Commissioner supported the bill, while hemp industry representatives and Senator Hoffner warned it could harm legitimate hemp retailers and access to hemp products. The final item, HS1 for HB 332, would ban sales and marketing of kratom products to those under 21 and direct the state to study testing and regulation of kratom and synthetic variants. Supporters, including the Delaware Healthcare Association and several recovery advocates, said age-gating is a reasonable first step and that synthetic products are the main concern; opponents and some senators argued the bill should go further and fully ban kratom or better distinguish synthetic products from natural leaf kratom. No formal roll-call votes were taken on the substantive bills during the transcript, and the meeting adjourned after public comment.

Transcript Highlights:

• THE FULL ARRAY OF CANNABINOIDS IN THE CANNABIS PLANT THEY ARE ABLE TO ACCESS WITH YOUR FULL PREMIUM DELTA

Transcript Highlights:

• Senate Bill 3 by Perry relates to the regulation of consumable hemp products and the hemp-derived cannabinoids

Bills: SJR36, SB26, SJR3, SJR48, SJR50, SJR51, SCR15, SCR17, SB3, SB5, SB12, SB18, SB1001, SB1002, SB1003, SB1004, SB1005, SB1006, SB1007, SB1008, SB1009, SB1010, SB1011, SB1012, SB1013, SB1014, SB1015, SB1016, SB1017, SB1018, SB1019, SB1020, SB1021, SB1022, SB1023, SB1024, SB1025, SB1026, SB1027, SB1028, SB1029, SB1030, SB1031, SB1032, SB1033, SB1034, SB1035, SB1036, SB1037, SB1038, SB1039, SB1040, SB1041, SB1042, SB1043, SB1044, SB1045, SB1046, SB1049, SB1050, SB1051, SB1052, SB1053, SB1054, SB1055, SB1056, SB1057, SB1058, SB1059, SB1060, SB1061, SB1062, SB1063, SB1064, SB1065, SB1066, SB1067, SB1068, SB1069, SB1070, SB1071, SB1072, SB1073, SB1074, SB1075, SB1076, SB1077, SB1078, SB1079, SB1080, SB1081, SB1082, SB1083, SB1084, SB1085, SB1086, SB1087, SB1088, SB1089, SB1090, SB1091, SB1092, SB1093, SB1094, SB1095, SB1096, SB1097, SB1098, SB1099, SB1100, SB1101, SB1102, SB1103, SB1104, SB1105, SB1106, SB1107, SB1108, SB1109, SB1110, SB1111, SB1112, SB1113, SB1114, SB1115, SB1116, SB1117, SB1118, SB1119, SB1120, SB1121, SB1122, SB1123, SB1124, SB1125, SB1126, SB1127, SB1128, SB1129, SB1130, SB1131, SB1132, SB1133, SB1134, SB1135, SB1136, SB1137, SB1138, SB1139, SB1140, SB1141, SB1142, SB1143, SB1144, SB1145, SB1146, SB1147, SB1148, SB1149, SB1150, SB1565

Keywords: teacher compensation, education funding, public school educators, teacher retention, teacher designation, dementia, Alzheimer's disease, Parkinson's disease, research funding, state budget, prevention, healthcare, medical research, Dementia Prevention and Research Institute, severance tax, oil and gas, Texas STRONG fund, economic stabilization, public health, property tax relief

Transcript Highlights:

• Iberane comes from a Central African shrub, and it's a psychoactive compound that has long been used
• It's a psychoactive compound. As I said at the very top, it's from a central African shrub.
• background that can better explain what it means to be a psychoactive compound.
• It's a psychoactive compound.
• So a psychoactive compound obviously has affects the psyche, not totally unlike a psilocybin thing.

Keywords: 928, house, all

Summary: The House Committee on Health, Human Services, and Elderly Affairs heard HB 1790-FN, which would address involuntary admissions for certain individuals with a substance use disorder. Representative Lucy Weber introduced the bill for Representative Long, and the committee heard extensive testimony both in support of and in opposition to the proposal. Opponents, including John Burns of SOS Recovery and Jake Barry of New Futures, argued that involuntary commitment is not well supported by research, can retraumatize people, may increase overdose risk after release, and could undermine New Hampshire’s existing recovery and harm-reduction efforts. They emphasized that treatment should be voluntary, trauma-informed, and paired with housing, recovery supports, and other community-based services. Representative Long said he was willing to accept DHHS’s request to amend the bill into a study commission, though he expressed concern that a prior state study had not led to action. He said the commission should focus on implementation details, including where people would be placed, staffing, withdrawal management, elopement prevention, length of commitment, and aftercare. He described involuntary commitment as one tool for people with severe dangerous addictions, distinct from drug court, and said it could help avoid criminal records. Committee members asked about capacity at New Hampshire Hospital and how the proposal would work in practice. DHHS officials Katya Fox and Cynthia Pabonis testified that the bill raises major policy and fiscal concerns. They said New Hampshire’s current system has benefited from investments in naloxone, medication-assisted treatment, recovery centers, and community-based services, and that those investments have helped reduce overdose deaths. They estimated the bill would require a new 70-bed facility costing about $40 million to build and about $33.3 million annually to operate, with only a small portion offset by insurance, plus more than $600,000 in annual legal costs and additional staffing and system changes. They also said New Hampshire Hospital has 185 beds, with about 100 patients typically ready for less restrictive settings, and that housing shortages are a major bottleneck. NAMI New Hampshire also testified in opposition, saying families often want any possible treatment for loved ones but still opposed the bill. No vote or final action was taken in the hearing.

Transcript Highlights:

• of certain products derived from hemp, including consumable hemp products and the hemp-derived cannabinoids

Transcript Highlights:

• of certain products derived from hemp, including consumable hemp products and the hemp-derived cannabinoids

Keywords: 997, house, all

Transcript Highlights:

• training and certain certification requirements to prescribe and administer certain drugs, including psychoactive

Transcript Highlights:

• Senate Bill 3 by Perry, relating to the regulation of consumable hemp products and the hemp-derived cannabinoids

Summary: The Senate met briefly and referred a large number of first-reading bills and resolutions to standing committees. The measures covered a wide range of topics, including hemp regulation, dementia research funding, parental rights and public education, municipal library funding, tax and local government issues, criminal justice, health care, education, transportation, natural resources, and election law. Several constitutional resolutions were also referred, including proposals related to the Dementia Prevention and Research Institute of Texas and a severance tax revenue fund. Most of the transcript consists of the reading of bill captions and committee referrals, with no substantive debate or testimony recorded. The listed measures included proposals on school uniforms, charter schools, Medicaid fraud remedies, insurance practices, occupational licensing for people with criminal convictions, water and sewer utility cybersecurity, agricultural protections, public meeting broadcasting, and various local and state governance matters. No votes were taken on the bills in this segment. The only formal action reflected was referral of the bills and resolutions to the appropriate committees, followed by adjournment of the Senate until the next scheduled meeting.

Transcript Highlights:

• point, even if those levels rise to a threshold above that in the semi-synthetic or synthetic cannabinoids

Transcript Highlights:

• They did not reference Delta 8, Delta 10, THCP, all of these other cannabinoid derivatives that we are
• very scary, and please consider banning the Delta-8 THC products and other synthetically derived cannabinoids

Summary: The committee heard a presentation from Jessica Spencer on cannabis, criminal justice, and mental health. She argued that marijuana products have become far more potent over time, that high-potency THC and hemp-derived products are widely available in Florida, and that daily or near-daily use can contribute to addiction, psychosis, and other mental health problems, especially for adolescents. She also said cannabis is linked to violent crime and suicide in some cases, urged more prevention funding in schools, stronger regulation of Delta-8 and similar products, better law enforcement and regulatory oversight, expanded treatment and diversion options, and more expungement opportunities for simple possession. Senators questioned her about potency data, testing methods, and whether she was claiming causation in violent cases; she said she was and noted she had worked on the No on 3 campaign while still favoring decriminalization of simple possession rather than full legalization. The committee then took up several bills. CS/SB 150, “Trooper’s Law,” was amended and reported favorably; it makes extreme animal cruelty during a declared emergency a third-degree felony, inspired by the rescue of a dog during Hurricane Milton. SB 234, the Jason Rayner Act, was reported favorably after debate over its changes to self-defense language and mandatory life imprisonment for manslaughter committed against a law enforcement officer; supporters said it closes a loophole exposed in the Rayner case, while opponents raised concerns about unintended consequences and mandatory sentencing. CS/SB 138, “Trenton’s Law,” also passed after amendment; it increases penalties for repeat DUI/vehicular homicide offenders and adds language on intoxicating substances, with supporters citing the death of Trenton Stewart and opponents warning about cannabis impairment standards and first refusal penalties. SB 130, dealing with compensation for wrongful incarceration, was reported favorably. The bill removes Florida’s “clean hands” bar, extends the filing deadline from 90 days to two years, and allows exonerees with factual innocence findings to pursue compensation and civil remedies. Support came from innocence and civil liberties advocates. The committee also received a law enforcement presentation from Florida Highway Patrol Lieutenant Channing Taylor on impaired driving enforcement, DRE training, and crash data, emphasizing that drug impairment—especially cannabis—plays a major role in fatal crashes and that officers rely on observation and field testing because roadside chemical testing is limited.

Transcript Highlights:

• There's also religious groups who are opposed to blood transfusions, psychoactive drugs, and maybe other
• There's also religious groups who are opposed to blood transfusions, psychoactive drugs, and maybe other
• There's also religious groups who are opposed to blood transfusions, psychoactive drugs, and maybe other

Keywords: 1189, house, all

Summary: The committee first recessed for a subcommittee meeting on HB 313, which concerned an open-meetings-related issue. In the subcommittee, members discussed concerns that the bill might be unnecessary because current law already allows a person to request an open meeting in advance; the subcommittee then voted ITL on HB 313 by voice vote and closed its work session. The full Judiciary Committee then reconvened and took up CACR 6, the proposed constitutional amendment on a “right to compute,” with members debating whether the language was too broad and could create unintended consequences. Supporters framed it as a forward-looking protection for computation resources and strong encryption, while opponents said it was too open-ended and better addressed by future legislation. The committee voted ITL on CACR 6 by a 17-0 roll call. The committee next turned to HB 232, as amended, concerning the rights of conscience for medical professionals. The amendment narrowed the bill to abortion-related objections, removed sterilization and artificial contraception, aligned the abortion definition with existing state law, and reduced damages from treble damages to actual damages. Supporters said the bill would protect conscience rights, give physicians and patients more choice, and could help attract providers to New Hampshire. Opponents argued it was overly broad, unclear in key definitions, and could interfere with employers’ ability to assign staff, especially in rural health settings. Members also raised concerns about the bill’s scope and enforcement, including the broad definition of “participate,” the lack of clarity around exceptions for providers whose services include abortion as a “major part,” emergency determinations, and the inclusion of nursing homes in the definition of health care institution. Some members argued the bill singled out abortion while other controversial medical procedures were not treated similarly, and others criticized the minimum-damages provision as potentially punitive and designed to deter participation. The discussion continued without a final vote shown in the transcript excerpt.

Transcript Highlights:

• Jeff Smith: Many of these products are mixed with other psychoactive substances or caffeine, mixing the

Transcript Highlights:

• THC is the primary psychoactive component in cannabis, and by using this as a common unit of analysis

Summary: At the May 14, 2025 JLARC meeting, members approved the January 9 minutes and adopted the 2025–27 biennial work plan with a minor typo correction. Staff reviewed the new work plan studies, including a drug take-back program fee/expenditure review due in December 2025 and a state energy performance standard compliance review due in June 2027, and noted JLARC’s recent session activity, including several bills passed related to JLARC work and recommendations. The committee then heard a preliminary cannabis market study showing Washington businesses likely produced two to three times more cannabis than retailers sold in 2023. Staff and RAND said LCB’s data systems are incomplete and unreliable, limiting regulation, tax verification, and diversion tracking; they recommended that LCB submit a plan by year-end for collecting accurate data by the end of 2026. Members and LCB discussed the long timeline for a new traceability system, the causes of missing sales and weight data, overproduction, diversion, and the social equity program’s effect on producer licenses. JLARC also presented a preliminary hospital oversight report concluding that the Department of Health is late on many hospital inspections, does not verify third-party inspection standards, does not review adverse health event correction plans, and could make hospital data more accessible. The committee discussed fee funding, language access, and inspection timing, and DOH said it would work on a strategic plan and continue coordinating with JLARC. Members also heard a preliminary report on the public records survivor exemption, which found agencies are using it but need more guidance; JLARC recommended keeping the exemption and having the Attorney General provide additional training. Finally, the committee approved the DDA processes and staffing final report for distribution, which recommended performance metrics, stronger data quality controls, and workforce planning; DDA concurred. JLARC also introduced proposed study questions for a future DCYF juvenile rehabilitation review focused on safety, security, programs, staffing, education, and contraband, and the meeting adjourned after members asked about scope and facility conditions.

Transcript Highlights:

• BIOLOGICAL PREDISPOSITION OF A SUSCEPTIBLE HOST FOR DEVELOPING A DEPENDENCE WHEN EXPOSED TO A PSYCHOACTIVE

Keywords: 999, senate, all

Transcript Highlights:

• And so when we, the number ones that we see are fentanyl, cannabinoids, and methamphetamine when reviewing
• In regards to cannabinoid exposure, cannabinoid does include THC products, including delta 8 and delta
• drastic increase since 2020 in fatal or near-fatal cases that have resulted due to an ingestion of cannabinoids
• Another scary number is that we have seen five deaths as a result of a cannabinoid ingestion.

Keywords: 958, all

Summary: The committee approved the October 22, 2025 minutes and then heard a presentation from the Child Fatality and Near Fatality External Review Panel on accidental ingestion of illegal drug products by children. Panel members said pediatric ingestions have become the most common case type they review, with the highest-risk children ages one to four, and that fatal cases have increased in recent years. They reported that the substances most often involved are fentanyl, cannabinoids including THC products, methamphetamine, and increasingly xylazine; they also noted a decline in buprenorphine-related ingestions, which they viewed as a positive trend. The panel used several case examples to highlight recurring problems in investigations and medical response, including delayed DCBS involvement, failure to administer Narcan, inadequate drug testing, lack of child abuse team involvement, and limited or absent law enforcement investigation. They said law enforcement issues are especially common in pediatric ingestion cases and are concentrated in Jefferson County and the Bluegrass/KIPA regions. One example involved a one-year-old who died from fentanyl and Benadryl intoxication; another involved a two-year-old who died after ingesting multiple substances; and a third involved a four-year-old with near-fatal THC gummy ingestion where delayed treatment worsened the child’s condition. They also described a 10-month-old THC ingestion case that resulted in a criminal abuse conviction, which they presented as an example without missed investigative opportunities. Committee members discussed possible policy responses, including creating a more specific criminal child abuse offense or clarifying existing abuse and neglect definitions to cover unsafe access to illegal drugs, while preserving room for true accidents and prescribed medications. Members also raised the need for statewide standardization in reporting, investigation, and medical response, and suggested the panel should be able to call in agencies such as law enforcement, DCBS, judges, and hospitals for closed-session review of selected cases. The panel chair said they were already pursuing meetings with LMPD and would provide Jefferson County-specific breakdowns, and members expressed interest in additional data and agency follow-up before considering legislation.

Transcript Highlights:

• Minor cannabinoids. Naturally occurring minor.

Summary: Senator Nathan Johnson presented a pair of bills he described as a comprehensive cannabis reform package for Texas. He said one bill would regulate hemp-derived THC with a 21-and-over purchase age, a 5 mg THC threshold, testing, labeling, licensing, packaging, and marketing standards, an advisory committee to report to the Legislature, and a tax structure that would direct revenue to public health, law enforcement, testing, and the Texas Compassionate Use Program. He also said the legislation reflects work by Chairman Ken King and is intended as an alternative to a total ban, which he argued would be unenforceable and undesirable. Johnson said the second bill would decriminalize possession and personal use of up to 2 ounces of marijuana, allow limited home cultivation, and create a path to expunction for people convicted of conduct that would no longer be illegal. He argued current Texas THC laws are inconsistent, harmful, and disproportionately affect communities of color, while also diverting law enforcement resources. He said the bills aim to create a more consistent and enforceable framework and to support medical THC use. Supportive testimony came from Shawn Salvahi, a veteran and Texas Cannabis Collective representative, who said decriminalization and homegrow would help veterans and first responders and that leaders should correct mistaken policy. Senator Molly Cook, an ER nurse, also backed Johnson’s approach and opposed SB 5, saying prohibition has failed, worsened safety, and created criminal and economic harms. In questions, Johnson said the Senate is likely to move SB 5, that the House could still change the outcome, and that he has been consistent in opposing a ban since 2018. The discussion also briefly touched on redistricting, with participants urging attention to flooding and criticizing proposed maps, but the main action was the presentation and defense of the THC bills ahead of floor consideration.

Transcript Highlights:

• The second is unlicensed intoxicating cannabinoids.
• In the time that I have left, I would like to briefly touch on intoxicating cannabinoids, which are frequently
• In the time that I have left, I wouldn't like to briefly touch on intoxicating cannabinoids, which are

Keywords: 959, house, all

Transcript Highlights:

• SB 3206, um, relating to cannabinoids.
• note that the Department of Health currently has the ability to change the allowable amount of cannabinoids
• It separates out industrial hemp from cannabinoid hemp and then it narrows the cannabinoid hemp products

Keywords: 912, senate, all

Summary: The committee first heard SB 888, which would bar operators of smart household security devices from sharing user data with law enforcement unless the user consents or police obtain a warrant. DCCA’s Office of Consumer Protection offered comments and Judiciary submitted written support. Several individuals also submitted written support. The committee recommended passage with amendments clarifying that the Office of Consumer Protection may enforce violations and adopting Judiciary’s recommended changes, while also deferring the effective date to July 1, 2050. The motion passed unanimously among members present, with one senator excused. The committee then took up SB 2777 on insurance disclosures. The bill would require authorized insurers to disclose claim-handling data to consumers, including claims open at the start of a period, closed with payment, closed without payment, and open at the end of the period. The committee described amendments to clarify the bill, remove a requirement for the DCCA insurance division to handle publication, and defer the effective date to July 1, 2050. The measure was passed with amendments and the recommendation was adopted, with one member voting no and another excused. In a joint Commerce and Consumer Protection/Judiciary hearing on SP2738 relating to tax haven abuse, the Department of Taxation offered comments and the Tax Foundation testified in opposition, arguing the state should rely on IRS audits and existing worldwide reporting rules rather than create a separate state approach. Other written testimony was noted in both support and opposition. The committees recommended passage with amendments adopting Taxation’s technical changes and deferring the effective date to July 1, 2050; the recommendation was adopted, with one senator noting reservations. The joint hearing then moved to health-related bills, including SB 2690 on primary care spending, SB 3103 on energy assistance, SB 3137 on Department of Health authority over food, drugs, and cosmetics, SB 3164 on child welfare service organizations, and SB 3206 on cannabinoids. SB 2690 drew strong support from physicians and advocates who said it would address primary care shortages, especially on neighbor islands, while HMSA and others warned a fixed spending percentage could raise costs and suggested a working group. SB 3164 drew support from child welfare providers and opposition from the Attorney General over indemnification language, and SB 3206 drew mixed testimony: state agencies raised federal-law and vagueness concerns, while hemp and cannabis advocates and some farmers supported the measure and urged broader legalization or amendments.